Results 191 to 200 of about 3,437,725 (340)
Influence of <i>MTHFD1L</i> variants on the susceptibility to hypertension in the Chinese Han population. [PDF]
Li Q +7 more
europepmc +1 more source
This study generates high‐fidelity synthetic longitudinal records for a million‐patient diabetes cohort, successfully replicating clinical predictive performance. However, deeper analysis reveals algorithmic biases and trajectory inconsistencies that escape standard quality metrics. These findings challenge current validation norms, demonstrating why a
Francisco Ortuño +5 more
wiley +1 more source
Hypertension in women of reproductive age: a cross-sectional analysis of prevalence and risk factors across 21 low-income and middle-income countries using Demographic and Health Surveys (2013-2023). [PDF]
Andriani H +3 more
europepmc +1 more source
This study analyzes gut bacteria in cholangiocarcinoma patients, revealing distinct microbial signatures that enable accurate disease detection. Species‐based diagnostic models achieved over 98% accuracy in identifying cholangiocarcinoma and distinguished it from other liver diseases. The research demonstrates that specific beneficial bacteria suppress
Benchen Rao +18 more
wiley +1 more source
Korea Hypertension Fact Sheet 2025: national trends in hypertension with a special analysis of hypertensive disorders of pregnancy. [PDF]
Kim HC +20 more
europepmc +1 more source
A targeted metabologenomic strategy integrating genomic and metabolomic hallmarks enabled the discovery of two new thioamides, thiogochangamides A and B, from bacteria. Their absolute configurations, previously unresolved within the thioviridamide family, were fully assigned through various chemical derivatizations and computational analysis ...
Young Eun Du +18 more
wiley +1 more source
Attributable Risk of Hypertension for Cardiovascular Disease. [PDF]
Mace HP, Clark D.
europepmc +1 more source
This review examines emerging combination immunotherapy strategies tailored to distinct tumor microenvironments and highlights next‐generation biomarkers that guide response prediction and treatment personalization. It integrates lessons from unsuccessful trials, addresses toxicity challenges, and outlines approaches for early biomarker discovery and ...
Asmita Pandey +6 more
wiley +1 more source

